MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioMarin Pharmaceutical
American company
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.
- MarketBeat aggregated consensus ratings and average price targets for Atour Lifestyle Holdings Limited. Morgan Stanley provided an overweight rating and price target.
- MarketBeat reported consensus recommendations and analyst ratings.
- MarketBeat aggregates various analyst ratings for Iamgold, noting Bank of America lowered its price objective from $22.50 to $21.00.